Proteosome influenza vaccine
US7399840B2 · kind B2 · utility
10Cited by
6References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 2004 |
| Grant date | Jul 15, 2008 |
| Priority date | — |
| Expiry date | Feb 2, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16234
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Improved forms of vaccines which comprise proteosomes and protein antigens are described. Vaccines which contain influenza HA as the antigen are used for illustration as to demonstrate efficacy. Improvements in the preparation of the vaccines themselves and the proteosome component are also included.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.